Info

amino group free or acylated with trifluoroacetyl group. The antiviral activities of these compounds were excellent and almost similar to each other, but those with trifluoroacetyl group at the 3"-amino group exhibited reduced cytotoxicity on Vero cell [133]. Likewise, N-palmitoyl derivatives of kanamycin B, tobramycin (3'-de-oxykanamycin B), dibekacin (3',4'-dideoxykanamycin B), and gentamicin (C1, C1a, and C2 complex), and a few other aminoglycosides were prepared, all of which showed excellent antiviral activity [134].

Aminoglycoside antibiotics (257), including kanamycin A, tobramycin, and gentamicin C complex, have been acylated with 1 mole of disodium carbenicillin (258) to give monoacylated derivatives (e.g., 259) (compounds 257-259). The resulting compounds were devoid of antibacterial activity against several strains tested, however, and showed no toxicity [135].

The 1-N-(D-threo- and racemic erythro-3-amino-2-hydroxylbutanoyl)-2',3'-di-deoxykanamycins A have been synthesized by using a standard esterification procedure to acylate the amino group of kanamycin A at position 1 with the corresponding 3-azido-2-hydroxybutanoic acid. The antibacterial activities of these compounds were less than that of amikacin having a 4-amino-2-hydroxybutanoyl moiety at the 1-amino group [136].

In a study on the fluorination-toxicity relationship, investigators prepared 1-N-acylamido derivatives of kanamycins, including (2R,3R)- and (2R,3S)-4-amino-3-fluoro-2-hydroxybutanoylkanamycins A and B (compounds 262-265). The 1-N-[(2R,3R)-4-amino-3-fluoro-2-hydroxybutanoyl] derivatives 262-264 showed activity similar to that of the related compounds [amikacin (2), arbekacin (260), and 1-N-[(S)-4-amino-2-hydroxybutanoyl]-3'-deoxykanamycin B 261], whereas the (2R,3S)-derivative 265 (compounds 260-265 ) showed decreased activity relative to 260. In toxicity, these compounds were similar to the parent antibiotics, and fluorination did not show any influence in the toxicity of the antibiotics [137].

6' -N-Benzamido derivatives of kanamycin A and tobramycin having a chromium complex in the benzene ring were prepared for use as metallotracers in im-munoassay studies. To make these compounds, N-hydroxysuccinimide-activated esters of these organochromiums were treated with kanamycin A or tobramycin to selectively produce the 6'-N-acylated derivative [138].

Different amino acid and peptide derivaties were used to synthesize a series of aminoacyl and dipeptidyl derivatives of kanamycin A and netilmicin modified at the 1-, and 6'-amino groups by selective acylation of the copper complexes of these antibiotics. However, none of these modified compounds were active against either gram-positive or gram-negative bacteria [139]. Recently, in a report from Abbott

0 0

Post a comment